AzTrials
AzTrials

FallsNCT06645080

Vision Screening in Hospitals for Older Adults Following a Fall

An observational study of Falls and Vision; Disorder, Loss, run by University of Nottingham at 1 site in United Kingdom.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Aims This study aims to improve the way vision is checked and sight loss treated in older adults (65 years or older), who attend hospital following a fall. Background Falling is common in older adults. As the number of older people grows, the number of falls is expected to increase as well. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Falls, Vision; Disorder, Loss
What is being tested?
Focus group or interview participation and Delphi survey participation
How many people
105 participants
Where
1 siteUnited Kingdom
Study dates
1 Feb 2025to Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Part one- Focus group study (with healthcare professionals): Members of the acute multidisciplinary team who care for falls patients at Nottingham University Hospitals NHS Trust (NUHT) will be recruited. Part two- Focus group study (with service users/ carers): Current patients of NUHT or others recruited from the public, aged 65 or over who have had a fall. Carers of people aged 65 or over who have had a fall. Part three- Intervention development using Delphi study: Professionals with relevant knowledge and experience of falls assessments and management in hospitals for older people or the assessment and management of impaired vision in older people.

Who may be able to join

  • Part one- Focus group study (with healthcare professionals):
  • Aged 18 years or above
  • Health professionals at NUHT
  • Must be involved in falls assessments/ management/ care of older falls patients as part of current/ previous role at NUHT.
  • Part two- Focus group study (with service users/ carers):
  • Adults ≥65 years
Show all 12Show fewer
  • Had at least 1 fall requiring attendance at an emergency department
  • Carers of adults ≥65 who have had at least 1 fall requiring attendance at an emergency department
  • Part three- Intervention development using Delphi study:
  • Aged 18 years or above
  • Knowledge and experience of falls assessments and management in hospitals for older people
  • Experience of the assessment and management of impaired vision in older people

Who cannot join

  • Those who are unable to give voluntary informed consent.
  • Those who have not sought secondary care following a fall.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Nottingham University Hospitals NHS Trust

    Nottingham, England, NG7 2UH

Other trials in United Kingdom

About this study

Official title: Vision Screening in Hospitals for Older Adults Following a Fall: an Intervention Development Study

Aims

This study aims to improve the way vision is checked and sight loss treated in older adults (65 years or older), who attend hospital following a fall.

Read more

Background

Falling is common in older adults. As the number of older people grows, the number of falls is expected to increase as well. Falling can affect a person's life in several ways: it can lead to pain, injuries, difficulty doing normal daily activities, weaker muscles, feeling isolated, losing independence and confidence, living in fear of falling, depression, difficulty in recovering from illnesses, developing other health problems more easily and a higher risk of death. Falls are a major health problem for the public and the United Kingdom (UK) spends more than £2 billion per year on caring for older adults who fall.

Problems with eyesight are also more common in older age and can have a similar effect on a person's independence, happiness and almost doubles their chances of falling. Sight loss in older age that is linked to falling is often treatable.

UK guidelines have been made to help prevent falls. These guidelines recommend checking for and treating sight loss in all older adults who attend hospital following a fall. However, this is only being done in a small number of hospitals. The reasons for this need to be investigated, in order to encourage and make it easier for health professionals to follow these guidelines.

Research has also shown that older adults, may be less likely to get their eyes tested regularly and attend hospital eye appointments. There are many reasons for this and vision screening whilst the patient is already receiving care in hospital, may be a good opportunity to address these issues. The views of the public are important for developing screening services that they understand and meets their needs. This study will gather the views of older people and their carers on hospital vision screening after a fall and the importance of looking after their eyes.

This study aims to improve the way vision is checked in older adults who attend hospital following a fall. This will help to identify and treat sight loss that may contribute to repeated falling. The study will combine the views of older adults and health professionals, to ensure that changes made meet patients' needs and are sustainable.

Design and methods

This study will have three parts:

  1. Focus groups asking health professionals about checking vision in patients who have fallen.
  2. Focus groups asking patients who have fallen and their carers about looking after their eyes.
  3. Development of a way of checking vision and treating sight loss in older adults who attend hospital following a fall.
Being tested
Focus group or interview participation, Delphi survey participation
Keywords
Falls, Vision screening, Intervention for falls prevention, Vision; Disorder, Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focus group or interview participationOther

    90 minute focus group or 60 minute interview participation

  • Delphi survey participationOther

    Participation in a modified two-round Delphi technique. Optional third round in the event of insufficient agreement in the second round.

Study groups in NCT06645080
Study groupRoleWhat they receive
Focus Group participants (health professionals)Not described
Receives: Other: Focus group or interview participation
Focus group participants (service users/ carers)Not described
Receives: Other: Focus group or interview participation
Delphi study participantsNot described
Receives: Other: Delphi survey participation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage agreement on Delphi survey components

    After each complete Delphi round, the percentage agreement of responses for each survey component will be calculated to help decide upon the subsequent Delphi survey items to be included. Or, if in the case of the final survey round, to help decide if a further round is required in the event of disagreement.

    Measured: Within 2 weeks of all Delphi round responses collected.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2024
  2. Study start1 Feb 2025
  3. Primary completionSep 2026 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06645080
Sponsor's protocol ID
24056
Status last verified
Apr 2026
First submitted
14 Oct 2024
Last updated
29 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Falls and Vision; Disorder, Loss, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage agreement on Delphi survey components (time frame: Within 2 weeks of all Delphi round responses collected.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in